Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 9Recruiting 3Active not recruiting 2Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 10Neoplasms 5Colorectal Neoplasms 4Neoplasm Metastasis 3Prostatic Neoplasms 2Lung Neoplasms 2Vomiting 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Skin Carcinoma 1Postoperative Complications 1Polycystic Ovary Syndrome 1Peripheral Arterial Disease 1Pancreatic Neoplasms 1Pancreatic Adenocarcinoma 1Pain 1Opioid-Related Disorders 1Nausea 1Multiple Myeloma 1Mouth Neoplasms 1Motor Activity 1Melanoma 1Medication Adherence 1Malignant Solid Neoplasm 1Lymphoma, Follicular 1Localised Prostate Cancer 1Laryngeal Neoplasms 1Ischemia 1Hypertension 1Hemianopsia 1

Interventions

Dexamethasone 16daratumumab 14Bortezomib 11Lenalidomide 9pomalidomide 7Calcium Dobesilate 6isatuximab 4belantamab mafodotin 4Cyclophosphamide 4carfilzomib 3Melphalan 3tocilizumab 2iberdomide 2dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Specimen Handling 2Maintenance 2Injections 2Immunotherapy, Adoptive 2Exercise Therapy 2Drug Therapy 2CT103A chimeric antigen receptor 2Biopsy 2zanubrutinib 1trametinib 1talquetamab 1selinexor 1pembrolizumab 1ixazomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Multiple Myeloma × Standard of Care × Clear all
NCT07181239 2025-09-18

Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients

Keymed Biosciences Co.Ltd

Phase 3 Not yet recruiting
280 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡